Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.22% |
| 2 | Technology | 4.92% |
| 3 | Industrials | 4.28% |
| 4 | Consumer Discretionary | 4.13% |
| 5 | Healthcare | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MACK
7976
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $126K | ﹤0.01% |
+32,595
| New | +$216K |
|
7977
PUT
Amkor Technology
AMKR
$14.6B
| $125K | ﹤0.01% |
14,500
-5,500
| -28% | -$50.2K |
|
7978
PUT
J. Jill
JILL
$278M
| $125K | ﹤0.01% |
3,192
-834
| -21% | -$22.6K |
|
7979
CALL
Teekay
TK
$1.09B
| $125K | ﹤0.01% |
16,100
-24,500
| -60% | -$204K |
|
7980
CALL
Veracyte
VCYT
$3.35B
| $125K | ﹤0.01% |
+13,400
| New | +$94.2K |
|
|
ANFI
7981
PUT
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $125K | ﹤0.01% |
56,200
+29,700
| +112% | +$90.6K |
|
|
GLDD
7982
DELISTED
Great Lakes Dredge & Dock
GLDD
| $124K | ﹤0.01% |
23,679
-4,935
| -17% | -$24.3K |
|
|
STG
7983
Sunlands Technology
STG
$44.2M
| $124K | ﹤0.01% |
+1,111
| New | +$127K |
|
7984
Acacia Research
ACTG
$448M
| $123K | ﹤0.01% |
29,581
+12,442
| +73% | +$47.8K |
|
7985
CALL
Lloyds Banking Group
LYG
$90.1B
| $123K | ﹤0.01% |
36,900
-10,300
| -22% | -$36.6K |
|
7986
CALL
Vericel Corp
VCEL
$2.26B
| $123K | ﹤0.01% |
12,700
+1,800
| +17% | +$22.4K |
|
|
ZN
7987
DELISTED
Zion Oil & Gas, Inc.
ZN
| $122K | ﹤0.01% |
30,116
-24,310
| -45% | -$95.3K |
|
|
ARQL
7988
CALL
DELISTED
Arqule Inc
ARQL
| $122K | ﹤0.01% |
+22,000
| New | +$84.1K |
|
|
SRCI
7989
CALL
DELISTED
SRC Energy Inc
SRCI
| $122K | ﹤0.01% |
11,100
-2,000
| -15% | -$22.3K |
|
|
FGP
7990
DELISTED
Ferrellgas Partners, L.P.
FGP
| $122K | ﹤0.01% |
36,208
-7,441
| -17% | -$26.1K |
|
|
AMR
7991
DELISTED
Alta Mesa Resources Inc
AMR
| $122K | ﹤0.01% |
+17,921
| New | +$129K |
|
7992
Ardelyx
ARDX
$1.05B
| $121K | ﹤0.01% |
32,743
+5,076
| +18% | +$23.6K |
|
|
NEPT
7993
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $121K | ﹤0.01% |
28
-6
| -18% | -$24.1K |
|
|
NH
7994
DELISTED
NantHealth, Inc
NH
| $121K | ﹤0.01% |
2,435
+1,274
| +110% | +$63.1K |
|
|
ANFI
7995
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $121K | ﹤0.01% |
54,546
+20,797
| +62% | +$63.5K |
|
7996
PUT
FS KKR Capital
FSK
$3.43B
| $120K | ﹤0.01% |
4,075
+1,525
| +60% | +$46.5K |
|
|
VNET
7997
CALL
VNET Group
VNET
$2.17B
| $120K | ﹤0.01% |
+12,400
| New | +$88.2K |
|
|
MTVA
7998
MetaVia Inc
MTVA
$7.8M
| – | – |
0
| – | – |
|
|
GEN
7999
DELISTED
Genesis Healthcare, Inc.
GEN
| $120K | ﹤0.01% |
+52,382
| New | +$101K |
|
|
LLEX
8000
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $120K | ﹤0.01% |
23,154
+4,976
| +27% | +$23.3K |
|
Similar funds
Ken Griffin's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
- Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Ken Griffin opened 1,572 new positions and closed 1,012 in Q2 2018.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.